Anti-TLR2 antibody [EPR20303]
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(41 Publications)
Rabbit Recombinant Monoclonal TLR2 antibody. Suitable for IP, WB and reacts with Mouse, Rat samples. Cited in 41 publications.
View Alternative Names
CD282, Toll-like receptor 2, Tlr2
- IP
Supplier Data
Immunoprecipitation - Anti-TLR2 antibody [EPR20303] (AB209217)
TLR2 was immunoprecipitated from 0.35 mg of RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate, treated with 1 μg/ml LPS for 6 hours, with ab209217 at 1/30 dilution.
Western blot was performed from the immunoprecipitate using ab209217 at 1/500 dilution.
VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.
Lane 1 : RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 6 hours, 10 μg (Input).
Lane 2 : ab209217 IP in RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 6 hours.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab209217 in RAW 264.7 whole cell lysate treated with 1 μg/ml LPS for 6 hours.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-TLR2 antibody [EPR20303] (ab209217)
Predicted band size: 89 kDa
Observed band size: 89 kDa
false
Exposure time: 1s
- WB
Supplier Data
Western blot - Anti-TLR2 antibody [EPR20303] (AB209217)
Blocking/Dilution buffer : 5% NFDM/TBST.
TLR2 is expressed in spleen but not in brain and heart according to the literature (PMID : 11777946).
All lanes:
Western blot - Anti-TLR2 antibody [EPR20303] (ab209217) at 1/1000 dilution
Lane 1:
Mouse spleen tissue lysate at 10 µg
Lane 2:
Mouse brain tissue lysate at 10 µg
Lane 3:
Mouse heart tissue lysate at 10 µg
Lane 4:
Rat spleen tissue lysate at 10 µg
Lane 5:
Rat brain tissue lysate at 10 µg
Lane 6:
Rat heart tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 89 kDa
Observed band size: 89 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-TLR2 antibody [EPR20303] (AB209217)
Blocking/Dilution buffer : 5% NFDM/TBST.
Expression of TLR2 in RAW 264.7 cells can be enhanced by LPS treatment according to the literature (PMID : 11067935).
All lanes:
Western blot - Anti-TLR2 antibody [EPR20303] (ab209217) at 1/10000 dilution
Lane 1:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 2:
RAW 264.7 whole cell lysate treated with 1 µg/ml lipopolysaccharides for 6 hours at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 89 kDa
Observed band size: 89 kDa
false
Exposure time: 3min
Related conjugates and formulations (2)
-
Anti-TLR2 antibody [EPR20303] - BSA and Azide free
-
Anti-TLR2 antibody [EPR20303] - Low endotoxin, Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TLR2 initiates signaling pathways that lead to the production of cytokines and chemokines helping to control infection. It forms dimers with other TLRs like TLR1 or TLR6 to expand its recognition range of microbial components. TLR2's activity is important for balancing pathogen recognition and avoiding overactive immune response. On macrophages TLR2 activation enhances their phagocytic ability.
Pathways
TLR2 plays roles in innate immune signaling pathways and inflammation pathways. It contributes significantly to the NF-kB and MAPK pathways which regulate inflammation and immune response. TLR2 often cooperates with proteins like MyD88 and TRAF6 in these pathways leading to downstream activation of transcription factors and production of pro-inflammatory molecules.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (41)
Recent publications for all applications. Explore the full list and refine your search
Journal of oral microbiology 17:2540823 PubMed40791819
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medicine 20:102 PubMed40597229
2025
Applications
Unspecified application
Species
Unspecified reactive species
Mediators of inflammation 2025:6808184 PubMed40520774
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed40471688
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1555079 PubMed40144659
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:2760 PubMed39843913
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of innate immunity 17:78-94 PubMed39773569
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 16: PubMed39458546
2024
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics 19:2380145 PubMed39018487
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental therapeutics 391:289-300 PubMed38849143
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com